Heart Institute BioRepository (HIBR) for Pediatric Heart Disease

The purpose of this protocol is to redefine the Heart Institute BioRepository (HIBR) to facilitate Investigator-initiated and programmatic basic, translational, clinical and outcomes research. For the purposes of this protocol, "tissue" will refer to any gross specimen obtained from a patient, including but not limited to blood, cardiovascular tissue, urine, saliva, and other tissues and bodily fluids, including explanted non-human prosthetics or grafts. In this context, "tissue" is synonymous with "sample" or "specimen." A "BioRepository" functions to systematically collect, maintain and govern tissue specimens.

NCT Number	NCT07478354
Lead Sponsor	Children's Hospital Medical Center, Cincinnati
Conditions	Cardiovascular Diseases (CVD)
Enrollment	5,000 participants
Start Date	2012-01-27
Primary Completion	2050-01-01 (estimated)
Study Completion	2050-01-01 (estimated)
Updated on ClinicalTrials.gov	2026-04-08